From the Cardiovascular Division, The Rayne Institute BHF Centre of Research Excellence, King's College London, St. Thomas' Hospital, United Kingdom (T.P., Y.H., S.R.R.);
Warwick Clinical Trials Unit and Heart of England NHS Foundation Trust, Warwick Medical School, University of Warwick, Coventry, United Kingdom (G.D.P.).
Circ Cardiovasc Interv. 2018 Jun;11(6):e005346. doi: 10.1161/CIRCINTERVENTIONS.117.005346.
There is wide variation in survival rates from out-of-hospital cardiac arrest (OHCA) and overall survival remains poor. There is an expert consensus that early reperfusion therapy in ST-elevation reduces mortality. The management of patients without ST-elevation, however, is controversial.
The Myocardial Ischaemia National Audit Project database is a national registry of all hospital admissions in England and Wales treated as an acute coronary syndrome (ACS). We examined temporal trends, over a 5-year period, of OHCAs identified by Myocardial Ischaemia National Audit Project, admitted to hospital and treated as ACS, the interventional management of these patients and clinical outcomes. Four hundred ten thousand four hundred sixty-two patients were admitted to hospital in England and Wales with ACS. Of these, 9421 presented with OHCA (2.30%). There was an increase in OHCA cases as a proportion of ACS between 2009 and 2013 (1.79% in 2009 versus 2.74% in 2013; <0.001). The rate of coronary angiography+percutaneous coronary intervention increased in ACS patients presenting with OHCA (54.9% in 2009 [876/1595] versus 66.3% in 2013 [884/1334]; <0.001). Cox proportional hazards model with time-varying exposure to coronary angiography demonstrated a significant reduction in mortality in both the ST-elevation (hazard ratio, 0.30; 95% confidence interval, 0.28-0.32; <0.05) and non-ST-elevation cohort (hazard ratio, 0.44; 95% confidence interval, 0.42-0.46; <0.001). Predictors of favorable outcome were synonymous with the selection criteria for patients undergoing coronary angiography±percutaneous coronary intervention.
This observational study showed that selection for coronary angiography±percutaneous coronary intervention was associated with reduced mortality in OHCA patients diagnosed with ACS. These data support the need for a randomized controlled trial.
院外心脏骤停(OHCA)的存活率差异很大,整体存活率仍然很低。专家共识认为,ST 段抬高的早期再灌注治疗可降低死亡率。然而,对于没有 ST 段抬高的患者的治疗存在争议。
心肌缺血国家审计项目数据库是英格兰和威尔士所有医院入院的全国登记处,作为急性冠状动脉综合征(ACS)进行治疗。我们研究了在 5 年期间,通过心肌缺血国家审计项目识别的 OHCA 患者的时间趋势,这些患者入院并被诊断为 ACS,对这些患者的介入管理以及临床结局。英格兰和威尔士有 410462 名患者因 ACS 入院。其中,9421 例为 OHCA(2.30%)。OHCA 病例占 ACS 的比例从 2009 年到 2013 年有所增加(2009 年为 1.79%,2013 年为 2.74%;<0.001)。ACS 患者中出现 OHCA 的患者接受冠状动脉造影+经皮冠状动脉介入治疗的比例增加(2009 年为 54.9%(876/1595),2013 年为 66.3%(884/1334);<0.001)。使用冠状动脉造影时变暴露的 Cox 比例风险模型显示,ST 段抬高组(危险比,0.30;95%置信区间,0.28-0.32;<0.05)和非 ST 段抬高组(危险比,0.44;95%置信区间,0.42-0.46;<0.001)的死亡率均显著降低。良好结局的预测因素与接受冠状动脉造影+经皮冠状动脉介入治疗患者的选择标准相同。
这项观察性研究表明,对接受冠状动脉造影+经皮冠状动脉介入治疗的患者进行选择与 ACS 诊断为 OHCA 患者的死亡率降低相关。这些数据支持需要进行随机对照试验。